Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ultragenyx Pharmaceutical Inc. (RARE)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Opaleye Management

James A. Silverman

80,000 $6,149 1.59%
2.
Opus Point Partners Management

Michael S. Weiss And Lindsay A. Rosenwald

6,311 $485 -14% 1.05%
3. 410,000 $31,517 1.05%
4.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

200,000 $15,374 +16% 0.59%
5.
Alkeon Capital Management

Panayotis Takis Sparaggis

491,296 $37,766 0.17%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$52.96 1,647 Officer, Director 2,559,741 2017-08-28 Filing
$52.40 5,853 Officer, Director 2,558,094 2017-08-28 Filing
$21.00 175,000 Large Shareholder, Other 3,260,240 2014-01-31 Filing
$21.00 4,500 Officer 84,255 2014-01-30 Filing
$21.00 5,000 Director 5,000 2014-01-30 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$73.38 6,000 Director 102,350 2018-10-08 Filing
$53.97 650 Director 108,350 2018-04-19 Filing
$122.58 400 Director 109,000 2015-07-27 Filing
$85.94 2,000 Director 109,400 2015-05-27 Filing
$68.65 10,500 Director 111,400 2015-05-12 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 5,596 $427 0%
2. 215 $16 0%
3. 9,400 $718 0%
4. 537 $41 0%